Status:
COMPLETED
Effect of Early Palliative Care on Quality of Life of Patients With Advanced Cancer: a Randomised Controlled Trial.
Lead Sponsor:
University Ghent
Collaborating Sponsors:
Vrije Universiteit Brussel
Fund for Scientific Research, Flanders, Belgium
Conditions:
Life-limiting Cancer With Prognosis of Approximately 1 Year
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The World Health Organization (WHO) defines palliative care as an approach to improve the quality of life of patients and their families facing life-threatening illness, through prevention and relief ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with life-limiting cancer (prognosis of approximately 1 year) are eligible if:
- Patients are within 12 weeks of referral from an other hospital after receiving first line treatment or within 8 to 12 weeks of a new diagnosis (histological and cytological confirmed):
- Metastatic and advanced pancreatic, stomach, oesophageal and biliary tract adenocarcinoma;
- Metastatic or advanced NSCLC (stage IIIB or IV) or metastatic SCLC,
- Malignant pleural mesothelioma
- Metastatic or advanced head and neck cancer (stage III or IV)
- Patients are within 12 weeks of progression after receiving treatment and have an prognosis of approximately 1 year:
- Metastatic and locally advanced colorectal cancer, with progression after second line treatment
- Metastatic or advanced prostate carcinoma, after second line treatment
- Advanced breast cancer with visceral and/or brain metastasis, with progression on second or third line treatment
- Metastatic melanoma,
- Metastatic or advanced kidney cancer,
- Metastatic or advanced bladder cancer after first line treatment,
- An Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 and ability to read and respond to questions in Dutch.
- Exclusion criteria:
- Patients under 18 years old
- Patients with impaired cognition
- Patients who met the palliative support team more then once or had a consultation within 6 months of inclusion.
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT01865396
Start Date
April 1 2013
End Date
April 1 2017
Last Update
December 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000